Belgium
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 51.26
|
Dec. 31, 2023 | USD 19.81 | 0.71% |
|
Belgium |
|
2 |
USD 30.56
|
Dec. 31, 2023 | USD 195.15 | -0.39% |
|
Belgium |
|
3 |
USD 19.11
|
Dec. 31, 2023 | USD 19.13 | -0.63% |
|
Belgium |
|
4 |
USD 16.25
|
Dec. 31, 2023 | USD 13.71 | -0.44% |
|
Belgium |
|
5 |
USD 4.02
|
Dec. 31, 2023 | USD 24.20 | -0.41% |
|
Belgium |
|
6 |
USD 0.00
|
Dec. 31, 2023 | USD 3.28 | -5.91% |
|
Belgium |
|
7 |
USD 0.00
|
Dec. 31, 2023 | USD 150.68 | -0.48% |
|
Belgium |
The Biotechnology company in Belgium with the highest Revenue Per Share is Tessenderlo Group NV (Brussels Stock Exchange: TESB.BR) at USD 51.26.
The Biotechnology company in Belgium with the lowest Revenue Per Share is Financière de Tubize SA (Brussels Stock Exchange: TUB.BR) at USD 0.00.
The top 10 Biotechnology companies in Belgium by Revenue Per Share are Tessenderlo Group NV, UCB SA, Azelis Group NV, Ion Beam Applications SA, Galapagos NV, Biotalys NV and Financière de Tubize SA.
The bottom 10 Biotechnology companies in Belgium by Revenue Per Share are Financière de Tubize SA, Biotalys NV, Galapagos NV, Ion Beam Applications SA, Azelis Group NV, UCB SA and Tessenderlo Group NV.